Fibroblast Activation Protein Inhibitor (FAPI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fibroblast Activation Protein Inhibitor (FAPI), covering 2025-06-05 to 2025-06-05. Get the full timeline:
Most recent: Clinical Trial Update: 68Ga-FAPI PET/CT in Malignant Tumors [NA]